Prostaglandin D
Journal
Clinical and experimental dermatology
ISSN: 1365-2230
Titre abrégé: Clin Exp Dermatol
Pays: England
ID NLM: 7606847
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
19
04
2020
revised:
17
06
2020
accepted:
10
07
2020
pubmed:
25
7
2020
medline:
22
9
2021
entrez:
25
7
2020
Statut:
ppublish
Résumé
Prostaglandin D
Substances chimiques
11,15-dioxo-9-hydroxy-2,3,4,5-tetranorprostan-1,20-dioic acid
0
Biomarkers
0
Prostaglandin D2
RXY07S6CZ2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
130-134Subventions
Organisme : The Japan Society for the Promotion of Science
ID : 17921666
Organisme : The Japan Society for the Promotion of Science
ID : 17H01509
Organisme : The Naito Foundation
Organisme : The Japan Agency for Medical Research and Development (AMED)
ID : 17935758
Organisme : The Nipponham Foundation.
Informations de copyright
© 2020 British Association of Dermatologists.
Références
Weidinger S, Novak N. Atopic dermatitis. Lancet 2016; 387: 1109-22.
Honda T, Kabashima K. Prostanoids in allergy. Allergol Int 2015; 64: 11-16.
Arai I, Takaoka A, Hashimoto Y et al. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice. Eur J Pharmacol 2007; 556: 207-14.
Maeda S, Nakamura T, Harada H et al. Prostaglandin D2 metabolite in urine is an index of food allergy. Sci Rep 2017; 7: 17687.
Inagaki S, Maeda S, Narita M et al. Urinary PGDM, a prostaglandin D2 metabolite, is a novel biomarker for objectively detecting allergic reactions of food allergy. J Allergy Clin Immunol 2018; 142:1634-6.e10.
Akdis CA, Akdis M, Bieber T et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy. Asthma and Immunology/PRACTALL Consensus Report. Allergy 2006; 61: 969-87.
European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD Index. Consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186: 23-31.
Furue M, Ebata T, Ikoma A et al. Verbalizing extremes of the visual analogue scale for pruritus: a consensus statement. Acta Dermato-Venereologica 2013; 93: 214-15.
Kakinuma T, Nakamura K, Wakugawa M et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001; 107: 535-41.
Satoh T, Moroi R, Aritake K et al. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. J Immunol 2006; 177: 2621-9.
Cho C, Nguyen A, Bryant KJ et al. Prostaglandin D2 metabolites as a biomarker of in vivo mast cell activation in systemic mastocytosis and rheumatoid arthritis. Immun Inflamm Dis 2015; 4: 64-9.
Takaoka A, Arai I, Sugimoto M et al. Role of scratch-induced cutaneous prostaglandin D production on atopic-like scratching behavior in mice. Exp Dermatol 2007; 16: 331-9.